Real Estate - Diversified
Compare Stocks
5 / 10Stock Comparison
CHCI vs WELL vs EQR vs AVB vs CPT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Residential
REIT - Residential
REIT - Residential
CHCI vs WELL vs EQR vs AVB vs CPT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Real Estate - Diversified | REIT - Healthcare Facilities | REIT - Residential | REIT - Residential | REIT - Residential |
| Market Cap | $180M | $150.37B | $24.56B | $25.61B | $10.87B |
| Revenue (TTM) | $56M | $11.63B | $3.12B | $3.04B | $1.18B |
| Net Income (TTM) | $14M | $1.43B | $954M | $1.05B | $388M |
| Gross Margin | 21.4% | 39.1% | 46.3% | 67.0% | 61.3% |
| Operating Margin | 16.6% | 4.4% | 28.5% | 30.1% | 18.1% |
| Forward P/E | 12.4x | 79.6x | 47.7x | 35.7x | 67.0x |
| Total Debt | $6M | $21.38B | $8.78B | $9.33B | $3.90B |
| Cash & Equiv. | $29M | $5.03B | $56M | $187M | $25M |
CHCI vs WELL vs EQR vs AVB vs CPT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Comstock Holding Co… (CHCI) | 100 | 753.0 | +653.0% |
| Welltower Inc. (WELL) | 100 | 423.6 | +323.6% |
| Equity Residential (EQR) | 100 | 108.2 | +8.2% |
| AvalonBay Communiti… (AVB) | 100 | 118.0 | +18.0% |
| Camden Property Tru… (CPT) | 100 | 113.3 | +13.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHCI vs WELL vs EQR vs AVB vs CPT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHCI is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 14.7%, EPS growth 83.1%, 3Y rev CAGR 18.2%
- 8.8% 10Y total return vs WELL's 225.2%
- PEG 0.28 vs EQR's 9.36
- Lower P/E (12.4x vs 67.0x), PEG 0.28 vs 2.87
WELL carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.15, Low D/E 49.5%, current ratio 5.34x
- Beta 0.15, yield 1.3%, current ratio 5.34x
- 35.8% FFO/revenue growth vs CPT's 1.9%
- Beta 0.15 vs CHCI's 0.74
EQR ranks third and is worth considering specifically for income & stability.
- Dividend streak 8 yrs, beta 0.37, yield 4.1%
- 4.1% yield, 8-year raise streak, vs CPT's 4.1%, (1 stock pays no dividend)
AVB is the clearest fit if your priority is quality.
- 34.6% margin vs WELL's 12.3%
Among these 5 stocks, CPT doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs CPT's 1.9% | |
| Value | Lower P/E (12.4x vs 67.0x), PEG 0.28 vs 2.87 | |
| Quality / Margins | 34.6% margin vs WELL's 12.3% | |
| Stability / Safety | Beta 0.15 vs CHCI's 0.74 | |
| Dividends | 4.1% yield, 8-year raise streak, vs CPT's 4.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | +46.7% vs CPT's -8.1% | |
| Efficiency (ROA) | 20.6% ROA vs WELL's 2.3%, ROIC 27.8% vs 0.5% |
CHCI vs WELL vs EQR vs AVB vs CPT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHCI vs WELL vs EQR vs AVB vs CPT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CHCI leads in 3 of 6 categories
AVB leads 1 • WELL leads 1 • EQR leads 1 • CPT leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVB leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 208.3x CHCI's $56M. AVB is the more profitable business, keeping 34.6% of every revenue dollar as net income compared to WELL's 12.3%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $56M | $11.6B | $3.1B | $3.0B | $1.2B |
| EBITDAEarnings before interest/tax | $10M | $2.8B | $1.9B | $1.8B | $867M |
| Net IncomeAfter-tax profit | $14M | $1.4B | $954M | $1.1B | $388M |
| Free Cash FlowCash after capex | $7M | $2.5B | $1.3B | $1.5B | $714M |
| Gross MarginGross profit ÷ Revenue | +21.4% | +39.1% | +46.3% | +67.0% | +61.3% |
| Operating MarginEBIT ÷ Revenue | +16.6% | +4.4% | +28.5% | +30.1% | +18.1% |
| Net MarginNet income ÷ Revenue | +24.9% | +12.3% | +30.6% | +34.6% | +32.8% |
| FCF MarginFCF ÷ Revenue | +12.6% | +21.9% | +42.7% | +49.7% | +60.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | +40.3% | +2.5% | +3.7% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -78.3% | +22.5% | -64.2% | -40.9% | +11.1% |
Valuation Metrics
CHCI leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 12.4x trailing earnings, CHCI trades at a 92% valuation discount to WELL's 154.4x P/E. Adjusting for growth (PEG ratio), CHCI offers better value at 0.28x vs AVB's 5.33x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $180M | $150.4B | $24.6B | $25.6B | $10.9B |
| Enterprise ValueMkt cap + debt − cash | $158M | $166.7B | $33.3B | $34.7B | $14.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.39x | 154.41x | 22.52x | 24.91x | 29.31x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 79.65x | 47.69x | 35.75x | 66.98x |
| PEG RatioP/E ÷ EPS growth rate | 0.28x | — | 4.42x | 5.33x | 1.26x |
| EV / EBITDAEnterprise value multiple | 14.91x | 66.86x | 15.55x | 19.02x | 16.38x |
| Price / SalesMarket cap ÷ Revenue | 3.52x | 14.10x | 7.92x | 8.43x | 6.91x |
| Price / BookPrice ÷ Book value/share | 3.44x | 3.38x | 2.23x | 2.21x | 2.54x |
| Price / FCFMarket cap ÷ FCF | 16.56x | 52.80x | 19.04x | 18.11x | 28.14x |
Profitability & Efficiency
CHCI leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CHCI delivers a 24.7% return on equity — every $100 of shareholder capital generates $25 in annual profit, vs $3 for WELL. CHCI carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to CPT's 0.88x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs AVB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +24.7% | +3.5% | +8.4% | +8.8% | +8.7% |
| ROA (TTM)Return on assets | +20.6% | +2.3% | +4.6% | +4.8% | +4.3% |
| ROICReturn on invested capital | +27.8% | +0.5% | +4.2% | +3.3% | +2.6% |
| ROCEReturn on capital employed | +19.9% | +0.6% | +5.7% | +4.4% | +3.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.12x | 0.49x | 0.77x | 0.79x | 0.88x |
| Net DebtTotal debt minus cash | -$22M | $16.3B | $8.7B | $9.1B | $3.9B |
| Cash & Equiv.Liquid assets | $29M | $5.0B | $56M | $187M | $25M |
| Total DebtShort + long-term debt | $6M | $21.4B | $8.8B | $9.3B | $3.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.26x | 5.58x | 5.07x | 3.89x |
Total Returns (Dividends Reinvested)
CHCI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CHCI five years ago would be worth $34,055 today (with dividends reinvested), compared to $10,011 for CPT. Over the past 12 months, WELL leads with a +46.7% total return vs CPT's -8.1%. The 3-year compound annual growth rate (CAGR) favors CHCI at 59.2% vs CPT's 1.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +45.9% | +15.2% | +7.9% | +3.0% | -4.8% |
| 1-Year ReturnPast 12 months | +45.2% | +46.7% | -2.0% | -6.5% | -8.1% |
| 3-Year ReturnCumulative with dividends | +303.5% | +191.6% | +17.0% | +13.4% | +4.8% |
| 5-Year ReturnCumulative with dividends | +240.5% | +206.1% | +5.5% | +10.4% | +0.1% |
| 10-Year ReturnCumulative with dividends | +881.5% | +225.2% | +28.9% | +30.7% | +66.4% |
| CAGR (3Y)Annualised 3-year return | +59.2% | +42.9% | +5.4% | +4.3% | +1.6% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.15 beta — it tends to amplify market swings less than CHCI's 0.74 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.7% from its 52-week high vs CPT's 86.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | 0.15x | 0.37x | 0.48x | 0.32x |
| 52-Week HighHighest price in past year | $19.72 | $219.59 | $71.80 | $209.86 | $119.89 |
| 52-Week LowLowest price in past year | $9.00 | $142.65 | $57.58 | $160.09 | $96.53 |
| % of 52W HighCurrent price vs 52-week peak | +88.6% | +97.7% | +91.3% | +87.7% | +86.6% |
| RSI (14)Momentum oscillator 0–100 | 53.8 | 54.5 | 67.3 | 69.3 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 23K | 2.6M | 2.4M | 941K | 1.0M |
Analyst Outlook
EQR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", EQR as "Hold", AVB as "Hold", CPT as "Hold". Consensus price targets imply 8.7% upside for WELL (target: $233) vs 3.6% for AVB (target: $191). For income investors, EQR offers the higher dividend yield at 4.11% vs WELL's 1.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | $233.25 | $70.61 | $190.78 | $111.58 |
| # AnalystsCovering analysts | — | 34 | 46 | 42 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +4.1% | +3.8% | +4.1% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 8 | 3 | 4 |
| Dividend / ShareAnnual DPS | — | $2.76 | $2.69 | $6.99 | $4.25 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.1% | +1.9% | +2.5% |
CHCI leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). AVB leads in 1 (Income & Cash Flow).
CHCI vs WELL vs EQR vs AVB vs CPT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHCI or WELL or EQR or AVB or CPT a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 1. 9% for Camden Property Trust (CPT). Comstock Holding Companies, Inc. (CHCI) offers the better valuation at 12. 4x trailing P/E, making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHCI or WELL or EQR or AVB or CPT?
On trailing P/E, Comstock Holding Companies, Inc.
(CHCI) is the cheapest at 12. 4x versus Welltower Inc. at 154. 4x. On forward P/E, AvalonBay Communities, Inc. is actually cheaper at 35. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Camden Property Trust wins at 2. 87x versus Equity Residential's 9. 36x.
03Which is the better long-term investment — CHCI or WELL or EQR or AVB or CPT?
Over the past 5 years, Comstock Holding Companies, Inc.
(CHCI) delivered a total return of +240. 5%, compared to +0. 1% for Camden Property Trust (CPT). Over 10 years, the gap is even starker: CHCI returned +881. 5% versus EQR's +28. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHCI or WELL or EQR or AVB or CPT?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 15β versus Comstock Holding Companies, Inc. 's 0. 74β — meaning CHCI is approximately 412% more volatile than WELL relative to the S&P 500. On balance sheet safety, Comstock Holding Companies, Inc. (CHCI) carries a lower debt/equity ratio of 12% versus 88% for Camden Property Trust — giving it more financial flexibility in a downturn.
05Which is growing faster — CHCI or WELL or EQR or AVB or CPT?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 1. 9% for Camden Property Trust (CPT). On earnings-per-share growth, the picture is similar: Camden Property Trust grew EPS 136. 0% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHCI or WELL or EQR or AVB or CPT?
Equity Residential (EQR) is the more profitable company, earning 36.
1% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EQR leads at 36. 3% versus 3. 3% for WELL. At the gross margin level — before operating expenses — AVB leads at 67. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHCI or WELL or EQR or AVB or CPT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Camden Property Trust (CPT) is the more undervalued stock at a PEG of 2. 87x versus Equity Residential's 9. 36x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, AvalonBay Communities, Inc. (AVB) trades at 35. 7x forward P/E versus 79. 6x for Welltower Inc. — 43. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 8. 7% to $233. 25.
08Which pays a better dividend — CHCI or WELL or EQR or AVB or CPT?
In this comparison, EQR (4.
1% yield), CPT (4. 1% yield), AVB (3. 8% yield), WELL (1. 3% yield) pay a dividend. CHCI does not pay a meaningful dividend and should not be held primarily for income.
09Is CHCI or WELL or EQR or AVB or CPT better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 15), 1. 3% yield, +225. 2% 10Y return). Both have compounded well over 10 years (WELL: +225. 2%, CHCI: +881. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHCI and WELL and EQR and AVB and CPT?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CHCI is a small-cap deep-value stock; WELL is a mid-cap high-growth stock; EQR is a mid-cap income-oriented stock; AVB is a mid-cap income-oriented stock; CPT is a mid-cap income-oriented stock. WELL, EQR, AVB, CPT pay a dividend while CHCI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.